发布求助
文献互助 智能选刊 最新文献

Immuno-oncology technology最新文献

筛选
英文 中文
25P Circulating tumor DNA is predictive of overall survival in patients with metastatic uveal melanoma 25P循环肿瘤DNA可预测转移性葡萄膜黑色素瘤患者的总生存率
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100907
E. Ramelyte , J. Kött , A. Lawless , A. Ciernik , S. Schneider , S. Freiberger , S. Orjuela , R. Dummer , R. Sullivan , M.P. Levesque , C. Gebhardt
{"title":"25P Circulating tumor DNA is predictive of overall survival in patients with metastatic uveal melanoma","authors":"E. Ramelyte , J. Kött , A. Lawless , A. Ciernik , S. Schneider , S. Freiberger , S. Orjuela , R. Dummer , R. Sullivan , M.P. Levesque , C. Gebhardt","doi":"10.1016/j.iotech.2024.100907","DOIUrl":"10.1016/j.iotech.2024.100907","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100907"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143128872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
7P ACOX2 disturbs the stability of MRE11-RAD50-NBS1 complex and shapes activated immune tumor microenvironment in clear cell renal cell carcinoma 7P ACOX2干扰透明细胞肾细胞癌MRE11-RAD50-NBS1复合体的稳定性，形成活化的免疫肿瘤微环境
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100891
S. Ye , W. Xu , H. Zhang , D. Ye
{"title":"7P ACOX2 disturbs the stability of MRE11-RAD50-NBS1 complex and shapes activated immune tumor microenvironment in clear cell renal cell carcinoma","authors":"S. Ye , W. Xu , H. Zhang , D. Ye","doi":"10.1016/j.iotech.2024.100891","DOIUrl":"10.1016/j.iotech.2024.100891","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100891"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143128925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
51P Unlocking CAR-T cell potential: Lipid metabolites in overcoming exhaustion in ovarian cancer 51P解锁CAR-T细胞潜能：脂质代谢物在卵巢癌中克服衰竭
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100862
X. Chang , M. Deng , W. Kong , X. Ji , J. Miao
{"title":"51P Unlocking CAR-T cell potential: Lipid metabolites in overcoming exhaustion in ovarian cancer","authors":"X. Chang , M. Deng , W. Kong , X. Ji , J. Miao","doi":"10.1016/j.iotech.2024.100862","DOIUrl":"10.1016/j.iotech.2024.100862","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100862"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143129094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
72P Concurrent local therapy (CLT) extends clinical benefit of tebentafusp (tebe) in metastatic uveal melanoma (mUM) patients (pts) 并发局部治疗（CLT）延长了替本他福（tebe）治疗转移性葡萄膜黑色素瘤（mUM）患者（pts）的临床获益
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100815
T. Lim , K. Montazeri , A. Desilets , A.N. Shoushtari , R. Seedor , M. Orloff , T. Sato , M. Caplan , M. El-Ashmawy , B. Izar , S. Khan , R.D. Carvajal , I. Mehmi , O. Hamid , R. Sullivan
{"title":"72P Concurrent local therapy (CLT) extends clinical benefit of tebentafusp (tebe) in metastatic uveal melanoma (mUM) patients (pts)","authors":"T. Lim , K. Montazeri , A. Desilets , A.N. Shoushtari , R. Seedor , M. Orloff , T. Sato , M. Caplan , M. El-Ashmawy , B. Izar , S. Khan , R.D. Carvajal , I. Mehmi , O. Hamid , R. Sullivan","doi":"10.1016/j.iotech.2024.100815","DOIUrl":"10.1016/j.iotech.2024.100815","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100815"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143175923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
77P A new prognostic index for patients with advanced BTC treated with cisplatin, gemcitabine and durvalumab 顺铂、吉西他滨和杜伐单抗联合治疗晚期BTC患者的新预后指标
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100820
M. Persano , L. Fornaro , L. Antonuzzo , T. Satake , H. Vandeputte , J. Lucchetti , J.W. Kim , O. Abidoye , I.G. Rapposelli , S. Tamberi , F. Finkelmeier , G. Giordano , F. Nicchetti , H.J. Chon , C. Yoo , S.L. Chan , M. Scartozzi , S. Lonardi , L. Rimassa , A. Casadei Gardini
{"title":"77P A new prognostic index for patients with advanced BTC treated with cisplatin, gemcitabine and durvalumab","authors":"M. Persano , L. Fornaro , L. Antonuzzo , T. Satake , H. Vandeputte , J. Lucchetti , J.W. Kim , O. Abidoye , I.G. Rapposelli , S. Tamberi , F. Finkelmeier , G. Giordano , F. Nicchetti , H.J. Chon , C. Yoo , S.L. Chan , M. Scartozzi , S. Lonardi , L. Rimassa , A. Casadei Gardini","doi":"10.1016/j.iotech.2024.100820","DOIUrl":"10.1016/j.iotech.2024.100820","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100820"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143176890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
79P Relevance of combined positive score (CPS) & low-dose immune checkpoint inhibitors (ICIs) in microsatellite stable (MSS) advanced gastric adenocarcinoma (GC): A multi-institution analysis 联合阳性评分（CPS）与低剂量免疫检查点抑制剂（ICIs）在微卫星稳定（MSS）晚期胃腺癌（GC）中的相关性：一项多机构分析
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100822
A. Ramaswamy , V. Shenoy , A. Bahl , A. Kapoor , V. Talwar , V. Muddu , A. Rauthan , R. Pinninti , A.M. Khan , S.J. Rajappa , N. Rohatgi , M. Sharma , P.G. Bhargava , A. Gupta , B. Sansar , U. Batra , V.S. Ostwal
{"title":"79P Relevance of combined positive score (CPS) & low-dose immune checkpoint inhibitors (ICIs) in microsatellite stable (MSS) advanced gastric adenocarcinoma (GC): A multi-institution analysis","authors":"A. Ramaswamy , V. Shenoy , A. Bahl , A. Kapoor , V. Talwar , V. Muddu , A. Rauthan , R. Pinninti , A.M. Khan , S.J. Rajappa , N. Rohatgi , M. Sharma , P.G. Bhargava , A. Gupta , B. Sansar , U. Batra , V.S. Ostwal","doi":"10.1016/j.iotech.2024.100822","DOIUrl":"10.1016/j.iotech.2024.100822","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100822"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143177307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
23P Non-small cell lung cancer DNA methylation profiles correlate with immune checkpoint inhibitor response 非小细胞肺癌DNA甲基化谱与免疫检查点抑制剂反应相关
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100905
J.M. Berger , E. Tomasich , V. Sunder-Plassmann , M. Kleinberger , P. Hettegger , L. Gottmann , I. Solano Henao , M. Korpan , U. Setinek , A. Valipour , M.J. Hochmair , L. Beer , H. Prosch , R. Kain , J. Furtner , G. Heller , M. Preusser , A.S. Berghoff
{"title":"23P Non-small cell lung cancer DNA methylation profiles correlate with immune checkpoint inhibitor response","authors":"J.M. Berger , E. Tomasich , V. Sunder-Plassmann , M. Kleinberger , P. Hettegger , L. Gottmann , I. Solano Henao , M. Korpan , U. Setinek , A. Valipour , M.J. Hochmair , L. Beer , H. Prosch , R. Kain , J. Furtner , G. Heller , M. Preusser , A.S. Berghoff","doi":"10.1016/j.iotech.2024.100905","DOIUrl":"10.1016/j.iotech.2024.100905","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100905"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143178089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
66MO Durvalumab after radiotherapy (RT) in patients (pts) with unresectable stage III NSCLC ineligible for chemotherapy (CT): Final analysis of the phase II DUART study 66MO Durvalumab在无法切除的不适合化疗（CT）的III期NSCLC患者（pts）放疗后（RT）： II期DUART研究的最终分析
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100809
A.R. Filippi , M. R. García Campelo , J-B. Paoli , D. Kowalski , C. Bennati , P. Borghetti , D. Cortinovis , A. Delmonte , C. Genova , R. Mroz , S. Nawrocki , I. Toledano , G. Tonini , F. Agustoni , G. Wetherill , I. Diaz Perez , N. Georgoulia , R. Dziadziuszko
{"title":"66MO Durvalumab after radiotherapy (RT) in patients (pts) with unresectable stage III NSCLC ineligible for chemotherapy (CT): Final analysis of the phase II DUART study","authors":"A.R. Filippi , M. R. García Campelo , J-B. Paoli , D. Kowalski , C. Bennati , P. Borghetti , D. Cortinovis , A. Delmonte , C. Genova , R. Mroz , S. Nawrocki , I. Toledano , G. Tonini , F. Agustoni , G. Wetherill , I. Diaz Perez , N. Georgoulia , R. Dziadziuszko","doi":"10.1016/j.iotech.2024.100809","DOIUrl":"10.1016/j.iotech.2024.100809","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100809"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143175999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
75P Real-world data of adebrelimab in the first-line treatment of patients with small cell lung cancer 75P阿布来单抗一线治疗小细胞肺癌患者的实际数据
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100818
Y. Song , B. Chen , W. Chen , H. Fei , Y. Zhang , H. Liu , R. Zhang , Y. Wu , T. Lv
{"title":"75P Real-world data of adebrelimab in the first-line treatment of patients with small cell lung cancer","authors":"Y. Song , B. Chen , W. Chen , H. Fei , Y. Zhang , H. Liu , R. Zhang , Y. Wu , T. Lv","doi":"10.1016/j.iotech.2024.100818","DOIUrl":"10.1016/j.iotech.2024.100818","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100818"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143176422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
28P Circulating biomarkers in non-small cell lung cancer patients treated with immune checkpoint inhibitors 使用免疫检查点抑制剂治疗的非小细胞肺癌患者的28P循环生物标志物
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100910
P. Ulivi , M. Canale , P. Cravero , M. Urbini , G. Marisi , F. Citarella , K. Andrikou , L. Crinò , A. Delmonte
{"title":"28P Circulating biomarkers in non-small cell lung cancer patients treated with immune checkpoint inhibitors","authors":"P. Ulivi , M. Canale , P. Cravero , M. Urbini , G. Marisi , F. Citarella , K. Andrikou , L. Crinò , A. Delmonte","doi":"10.1016/j.iotech.2024.100910","DOIUrl":"10.1016/j.iotech.2024.100910","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100910"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143139346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信